« Back
Home /
Olodaterol

Olodaterol

Item no.	TMO-T3457-2mg
Manufacturer	TargetMol
CASRN	868049-49-4
Amount	2 mg
Quantity options	10 mg 1 mg 25 mg 2 mg 5 mg
Category	Metabolism Diabetes Glucose Homeostasis Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Citations	1. Bouyssou T, et al. Discovery of olodaterol, a novel inhaled beta2-adrenoceptor agonist with a 24 h bronchodilatory efficacy. Bioorg Med Chem Lett. 2010 Feb 15;20(4):1410-4.
Smiles	COc1ccc(CC(C)(C)NC[C@H](O)c2cc(O)cc3NC(=O)COc23)cc1
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	Striverdi Respimat,BI1744
Shipping Condition	Cool pack
Available
Manufacturer - Targets	Adrenergic Receptor
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	386.45
Description	Olodaterol is a novel, long-acting beta2-adrenergic agonist (LABA) that exerts its pharmacological effect by binding and activating beta2-adrenergic receptors located primarily in the lungs.
Pathways	Neuroscience\|\|\|GPCR/G Protein
Bioactivity	Olodaterol (BI1744) is a long acting beta2-adrenoceptor agonist with an EC50 of 1.4+/-0.08 nM.
Receptor	beta2-adrenoceptor

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T3457-2mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 2 mg

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question